NCT07063342View on ClinicalTrials.gov

A Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, and to Explore the Effect of Food After Multiple Doses of Selected Prototypes in Healthy Adult Participants

PHASE1RecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 27, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Healthy Volunteers
Interventions
DRUG

Xanomeline/Trospium Chloride Capsule

Specified dose on specified days

DRUG

Xanomeline Enteric Capsule

Specified dose on specified days

DRUG

Trospium Chloride

Specified dose on specified days

Trial Locations (1)

NG1 6JS

RECRUITING

Quotient Sciences, Nottingham

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT07063342 - A Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, and to Explore the Effect of Food After Multiple Doses of Selected Prototypes in Healthy Adult Participants | Biotech Hunter | Biotech Hunter